Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

The University of Notre Dame Australia

2016

Stroke

Articles 1 - 4 of 4

Full-Text Articles in Medicine and Health Sciences

Triage, Treatment And Transfer Of Patients With Stroke In Emergency Department Trial (The T3 Trial): A Cluster Randomised Trial Protocol, Sandy Middleton, Chris Levi, Simeon Dale, N. Wah Cheung, Elizabeth Mcinnes, Julie Considine, Catherine D'Este, Dominique A. Cadilhac, Jeremy Grimshaw, Richard Gerraty, Louise E. Craig, Verena Schadewaldt, Patrick Mcelduff, Mark Fitzgerald, Clare Quinn, Greg Cadigan, Sonia Denisenko, Mark Longworth, Jeanette Ward, T3 Trialist Collaborators Jan 2016

Triage, Treatment And Transfer Of Patients With Stroke In Emergency Department Trial (The T3 Trial): A Cluster Randomised Trial Protocol, Sandy Middleton, Chris Levi, Simeon Dale, N. Wah Cheung, Elizabeth Mcinnes, Julie Considine, Catherine D'Este, Dominique A. Cadilhac, Jeremy Grimshaw, Richard Gerraty, Louise E. Craig, Verena Schadewaldt, Patrick Mcelduff, Mark Fitzgerald, Clare Quinn, Greg Cadigan, Sonia Denisenko, Mark Longworth, Jeanette Ward, T3 Trialist Collaborators

Health Sciences Papers and Journal Articles

Background: Internationally recognised evidence-based guidelines recommend appropriate triage of patients with stroke in emergency departments (EDs), administration of tissue plasminogen activator (tPA), and proactive management of fever, hyperglycaemia and swallowing before prompt transfer to a stroke unit to maximise outcomes. We aim to evaluate the effectiveness in EDs of a theory-informed, nurse-initiated, intervention to improve multidisciplinary triage, treatment and transfer (T3) of patients with acute stroke to improve 90-day death and dependency. Organisational and contextual factors associated with intervention uptake also will be evaluated.

Methods: This prospective, multicentre, parallel group, cluster randomised trial with blinded outcome assessment will be conducted …


The Disability Rate Of 5-Year Post-Stroke And Its Correlation Factors: A National Survey In China, Y Yang, Y-Z Shi, N Zhang, S Wang, G Ungvari, C Ng, Y-L Wang, X-Q Zhao, Y-J Wang, C-X Wang, Y-T Xiang Jan 2016

The Disability Rate Of 5-Year Post-Stroke And Its Correlation Factors: A National Survey In China, Y Yang, Y-Z Shi, N Zhang, S Wang, G Ungvari, C Ng, Y-L Wang, X-Q Zhao, Y-J Wang, C-X Wang, Y-T Xiang

Medical Papers and Journal Articles

Few studies on long-term functional outcome have been conducted in post-stroke patients in China. The objective of this study was to conduct a nationwide survey in China to investigate the 5-year prevalence of post-stroke disability and its correlation factors. A total of 893 patients with ischemic stroke were included. Demographic, clinical and neuro-imaging information were collected with standardized instruments that assessed stroke severity, depression, cognitive impairment, stroke recurrence and physical disability. Disability was assessed with the modified Ranking Score (mRS), of which a cutoff score _2 indicates disability. Statistical analysis included chi-square tests, two independent samples t-tests, Mann-Whitney U test …


Poly-Arginine Peptides Reduce Infarct Volume In A Permanent Middle Cerebral Artery Rat Stroke Model, D Milani, V Clark, J Cross, R Anderton, N Knuckey, B Meloni Jan 2016

Poly-Arginine Peptides Reduce Infarct Volume In A Permanent Middle Cerebral Artery Rat Stroke Model, D Milani, V Clark, J Cross, R Anderton, N Knuckey, B Meloni

Medical Papers and Journal Articles

Background: We recently reported that poly-arginine peptides have neuroprotective properties both in vitro and in vivo. In cultured cortical neurons exposed to glutamic acid excitotoxicity, we demonstrated that neuroprotective potency increases with polymer length plateauing at R15 to R18 (R = arginine resides). In an in vivo study in rats, we also demonstrated that R9D (R9 peptide synthesised with D-isoform amino acids) administered intravenously at a dose of 1000 nmol/kg 30 min after permanent middle cerebral artery occlusion (MCAO) reduces infarct volume. Based on these positive in vitro and in vivo findings, we decided to examine the neuroprotective efficacy of …


The R18 Polyarginine Peptide Is More Effective Than The Tat-Nr2b9c (Na-1) Peptide When Administered 60 Minutes After Permanent Middle Cerebral Artery Occlusion In The Rat, D Milani, N Knuckey, R Anderton, J Cross, B Meloni Jan 2016

The R18 Polyarginine Peptide Is More Effective Than The Tat-Nr2b9c (Na-1) Peptide When Administered 60 Minutes After Permanent Middle Cerebral Artery Occlusion In The Rat, D Milani, N Knuckey, R Anderton, J Cross, B Meloni

Medical Papers and Journal Articles

We examined the dose responsiveness of polyarginine R18 (100, 300, and 1000 nmol/kg) when administered 60 minutes after permanent middle cerebral artery occlusion (MCAO).The TAT-NR2B9c peptide, which is known to be neuroprotective in rodent and nonhuman primate stroke models, served as a positive control. At 24 hours afterMCAO, there was reduced total infarct volume in R18 treated animals at all doses, but this reduction only reached statistical significance at doses of 100 and 1000 nmol/kg. The TAT-NR2B9c peptide reduced infarct volume at doses of 300 and 1000 nmol/kg, but not to a statistically significant extent, while the 100 nmol/kg dose …